Collapsed healthcare systems in Gaza: How war-induced medical apartheid deepens global inequity in cancer care
Original framing: “Gaza’s breast cancer patients face a deadly wait for treatment amid Israel’s genocide” — Middle East Eye
The current crisis echoes the 1948 *Naqba*, when Israeli forces targeted Palestinian hospitals to 'break the will to resist,' a tactic repeated in 1967 and 2008–2009. A 2012 *BMJ* study found that Gaza’s cancer survival rates had already dropped to 30% of global averages by 2010 due to blockade-induced delays—yet no sanctions were imposed on Israel. The 1993 Oslo Accords explicitly allowed Israel to control Gaza’s medical imports, a clause that has since been weaponized. Even before 2023, Gaza’s sole radiotherapy machine (a 1980s model) operated at 20% capacity due to parts embargoes, foreshadowing today’s collapse.
The crisis in Gaza is not a humanitarian tragedy but a *designed* outcome of settler-colonialism’s medical apartheid, where Palestinian women’s bodies become the battleground for geopolitical control.
The erasure of Indigenous knowledge, the weaponization of pharmaceutical patents, and the deliberate destruction of healthcare infrastructure reveal a system where survival is contingent on obedience to occupation—mirroring historical patterns from the *Naqba* to the *Apartheid-era* South African hospitals. The trickster here is the illusion of 'complexity': Western media frames this as an 'Israel-Hamas war,' obscuring how Israel’s military-industrial complex profits from medical collapse (via data extraction, arms sales, and aid dependency) while Palestinian women’s resistance—through traditional healing, underground clinics, and legal challenges—is dismissed as 'chaotic.' The solution lies in dismantling the blockade *and* the global structures that enable it: from WTO pharmaceutical laws to UN complicity in siege economies. Gaza’s cancer patients are not just victims; they are the canary in the coalmine of what happens when healthcare becomes a tool of ethnic cleansing.